These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29518542)

  • 1. PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders.
    Cervenka S
    Neurosci Lett; 2019 Jan; 691():26-34. PubMed ID: 29518542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors.
    Stahl SM
    CNS Spectr; 2017 Aug; 22(4):305-311. PubMed ID: 28758887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of probes for PET imaging of dopamine D3 receptors.
    Doot RK; Dubroff JG; Labban KJ; Mach RH
    Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of agonist radioligands for imaging of brain dopamine D2/D3 receptors in vivo with positron emission tomography.
    Finnema SJ; Bang-Andersen B; Wikström HV; Halldin C
    Curr Top Med Chem; 2010; 10(15):1477-98. PubMed ID: 20583987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
    Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular imaging of psychiatric disorders].
    Takahashi H; Suhara T
    Nihon Rinsho; 2007 Feb; 65(2):336-41. PubMed ID: 17302281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 10. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.
    Schmieg N; Rocchi C; Romeo S; Maggio R; Millan MJ; Mannoury la Cour C
    J Neurochem; 2016 Mar; 136(5):1037-51. PubMed ID: 26685100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D3 Receptors and PET Imaging.
    Koohsari S; Yang Y; Matuskey D
    Curr Top Behav Neurosci; 2023; 60():251-275. PubMed ID: 35711027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of Striatal Dopamine Receptor Binding in Suicide.
    Fitzgerald ML; Kassir SA; Underwood MD; Bakalian MJ; Mann JJ; Arango V
    Neuropsychopharmacology; 2017 Mar; 42(4):974-982. PubMed ID: 27402414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [
    Naylor JE; Hiranita T; Matazel KS; Zhang X; Paule MG; Goodwin AK
    Drug Alcohol Depend; 2017 Oct; 179():254-259. PubMed ID: 28818716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of dopamine D1 and D2 receptors to amygdala activity in human.
    Takahashi H; Takano H; Kodaka F; Arakawa R; Yamada M; Otsuka T; Hirano Y; Kikyo H; Okubo Y; Kato M; Obata T; Ito H; Suhara T
    J Neurosci; 2010 Feb; 30(8):3043-7. PubMed ID: 20181600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.
    Mukherjee J; Majji D; Kaur J; Constantinescu CC; Narayanan TK; Shi B; Nour MT; Pan ML
    Synapse; 2017 Mar; 71(3):. PubMed ID: 27864853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
    Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice.
    Wong JY; Clifford JJ; Massalas JS; Finkelstein DI; Horne MK; Waddington JL; Drago J
    Eur J Pharmacol; 2003 Jul; 472(1-2):39-47. PubMed ID: 12860471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.
    Hofford RS; Wellman PJ; Eitan S
    J Psychopharmacol; 2012 Oct; 26(10):1355-65. PubMed ID: 22522973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.